Psychotic Depression Induced by Adalimumab in a Patient with Ankylosing Spondylitis: A Case Report

dc.contributor.authorErbay, Lale Gönenir
dc.contributor.authorKartal Sarıoğlu, Fatma
dc.contributor.authorDarılmaz, Cengiz
dc.contributor.authorKartalcı, Şükrü
dc.date.accessioned2021-08-16T11:55:51Z
dc.date.available2021-08-16T11:55:51Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAbstract: Tumor Necrosis Factor Alpha antagonists, which are used for the treatment of inflammatory diseases, are considered to be associated with psychiatric diseases.Herein we have reported an adult ankylosing spondylitis case with psychotic depression induced by adalimumab therapy and improved after treatment. We aimed both to discuss the relationship between psychiatric disease and inflammatory factor over this case and to make contribution to the literature. A 57-year-old male patient. He had experienced depressive symptoms nearly 5 months ago after 15 days of adalimumab therapy started for ankylosing spondylitis. Meanwhile, the symptoms of the patient, who continued adalimumab therapy once every two weeks, progressed and accompanied by psychotic symptoms such as disorganized speaking and behavior. The patient was admitted to the psychiatry clinic; however, his complaints did not significantly improve with treatment but rapidly regressed after discontinuation of adalimumab therapy. To our knowledge, there is limited data on the mood episodes triggered by adalimumab. In the present case, presence of a connection between symptom onset and the date of starting the medication, as well as rapid symptom regression with discontinuation of the medication, was considered as “potential adverse drug effect” according to the Naranjo Algorithm. This suggests that alteration in proinflammatory processes such as Tumor Necrosis Factor (TNF) might be associated with the onset of mood episodes. Further studies would be important in understanding the role of immune system in the pathophysiology of depression, particularly the sub-types such as psychotic depression.en_US
dc.identifier.citationERBAY L. G,SARIOĞLU F. K,DARILMAZ C,KARTALCI Ş (2018). Psychotic Depression Induced by Adalimumab in a Patient with Ankylosing Spondylitis: A Case Report. Psychiatry and behavioral sciences (Online), 8(4), 204 - 207. Doi: 10.5455/PBS.20180515083252en_US
dc.identifier.doi10.5455/PBS.20180515083252en_US
dc.identifier.endpage207en_US
dc.identifier.issn2636-834X
dc.identifier.issue4en_US
dc.identifier.startpage204en_US
dc.identifier.trdizinid374136en_US
dc.identifier.urihttps://doi.org/10.5455/PBS.20180515083252
dc.identifier.urihttps://hdl.handle.net/11616/42100
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/374136
dc.identifier.volume8en_US
dc.identifier.wosWOS:000640972900009en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isotren_US
dc.relation.ispartofPsychiatry and behavioral sciences (Online)en_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titlePsychotic Depression Induced by Adalimumab in a Patient with Ankylosing Spondylitis: A Case Reporten_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Makale Dosyası.pdf
Boyut:
66.91 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Doyası
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: